283 related articles for article (PubMed ID: 14671489)
1. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
Griffiths AM
Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
[No Abstract] [Full Text] [Related]
2. Monitoring of AZA/6-MP treatment in children with IBD is necessary.
Dubinsky MC
Inflamm Bowel Dis; 2003 Nov; 9(6):386-8; discussion 392-3. PubMed ID: 14671488
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics and IBD: TPMT and thiopurines.
Sandborn WJ
Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S35-7. PubMed ID: 15168829
[No Abstract] [Full Text] [Related]
4. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Thomas CW; Lowry PW; Franklin CL; Weaver AL; Myhre GM; Mays DC; Tremaine WJ; Lipsky JJ; Sandborn WJ
Inflamm Bowel Dis; 2003 Jul; 9(4):237-45. PubMed ID: 12902847
[TBL] [Abstract][Full Text] [Related]
5. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
6. Optimizing thiopurine therapy in inflammatory bowel disease.
Chevaux JB; Peyrin-Biroulet L; Sparrow MP
Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
[TBL] [Abstract][Full Text] [Related]
7. What are the rules when treatment with 6-MP/AZA is started?
Korelitz BI
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S262-3. PubMed ID: 18816727
[No Abstract] [Full Text] [Related]
8. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
9. Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and a survey of Canadian gastroenterologists.
Wallace TM; Veldhuyzen van Zanten SJ
Can J Gastroenterol; 2001 Jan; 15(1):21-8. PubMed ID: 11173323
[TBL] [Abstract][Full Text] [Related]
10. [Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].
Bessard G; Hardy G; Chartier A; Stanke-Labesque F
Therapie; 2004; 59(1):71-5. PubMed ID: 15199672
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
12. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
Su CG; Stein RB; Lewis JD; Lichtenstein GR
Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
15. 6TG: when less is more than you bargained for.
Mahadevan U
Inflamm Bowel Dis; 2003 Nov; 9(6):394-5. PubMed ID: 14677541
[No Abstract] [Full Text] [Related]
16. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
17. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gisbert JP; Gomollón F; Maté J; Pajares JM
Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
[No Abstract] [Full Text] [Related]
18. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.
Dong XW; Zheng Q; Zhu MM; Tong JL; Ran ZH
World J Gastroenterol; 2010 Jul; 16(25):3187-95. PubMed ID: 20593505
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
Hawwa AF; Millership JS; Collier PS; Vandenbroeck K; McCarthy A; Dempsey S; Cairns C; Collins J; Rodgers C; McElnay JC
Br J Clin Pharmacol; 2008 Oct; 66(4):517-28. PubMed ID: 18662289
[TBL] [Abstract][Full Text] [Related]
20. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
